{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T15:17:30Z","timestamp":1760887050813,"version":"build-2065373602"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,19]]},"DOI":"10.7759\/cureus.94918","type":"journal-article","created":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T14:43:27Z","timestamp":1760885007000},"source":"Crossref","is-referenced-by-count":0,"title":["A Rare, Potentially Fatal Complication of a Common Virus: Epstein-Barr Virus-Induced Hemophagocytic Lymphohistiocytosis in Adolescence"],"prefix":"10.7759","author":[{"given":"Bakr","family":"Alhayek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaowei","family":"Malone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joelian Andrew","family":"Mislay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan T","family":"Cardew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asha","family":"Ramsakal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.21037\/aob-25-3","article-title":"Hemophagocytic lymphohistiocytosis (HLH): a narrative review of the pathogenesis, clinical presentation, diagnosis, treatment, and prognosis","volume":"10","author":"Toumeh N","year":"2025","unstructured":"Toumeh N, Abu-Zeinah KF, Godby RC. Hemophagocytic lymphohistiocytosis (HLH): a narrative review of the pathogenesis, clinical presentation, diagnosis, treatment, and prognosis. Annals of Blood. 2025, 10:10.21037\/aob-25-3","journal-title":"Annals of Blood"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra2314005","article-title":"Hemophagocytic lymphohistiocytosis","volume":"392","author":"Henter JI","year":"2025","unstructured":"Henter JI. Hemophagocytic lymphohistiocytosis. N Engl J Med. 2025, 392:584-98. 10.1056\/NEJMra2314005","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.27929","article-title":"Challenges in the diagnosis of hemophagocytic lymphohistiocytosis: Recommendations from the North American Consortium for Histiocytosis (NACHO)","volume":"66","author":"Jordan MB","year":"2019","unstructured":"Jordan MB, Allen CE, Greenberg J, et al.. Challenges in the diagnosis of hemophagocytic lymphohistiocytosis: Recommendations from the North American Consortium for Histiocytosis (NACHO). Pediatr Blood Cancer. 2019, 66:10.1002\/pbc.27929","journal-title":"Pediatr Blood Cancer"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/joim.13432","article-title":"Incidence and survival of haemophagocytic lymphohistiocytosis: a population-based cohort study from England","volume":"291","author":"West J","year":"2022","unstructured":"West J, Card TR, Bishton MJ, et al.. Incidence and survival of haemophagocytic lymphohistiocytosis: a population-based cohort study from England. J Intern Med. 2022, 291:493-504. 10.1111\/joim.13432","journal-title":"J Intern Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.18617","article-title":"Epidemiology of haemophagocytic lymphohistiocytosis at the population level in Germany","volume":"201","author":"Kuron D","year":"2023","unstructured":"Kuron D, Voran JC, von Samson-Himmelstjerna FA, Baldus C, Kunzendorf U, Schulte K, Kolbrink B. Epidemiology of haemophagocytic lymphohistiocytosis at the population level in Germany. Br J Haematol. 2023, 201:285-9. 10.1111\/bjh.18617","journal-title":"Br J Haematol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2023.102143","article-title":"Epidemiology, characteristics, and outcomes of adult haemophagocytic lymphohistiocytosis in the USA, 2006-19: a national, retrospective cohort study","volume":"62","author":"Abdelhay A","year":"2023","unstructured":"Abdelhay A, Mahmoud AA, Al Ali O, Hashem A, Orakzai A, Jamshed S. Epidemiology, characteristics, and outcomes of adult haemophagocytic lymphohistiocytosis in the USA, 2006-19: a national, retrospective cohort study. EClinicalMedicine. 2023, 62:10.1016\/j.eclinm.2023.102143","journal-title":"EClinicalMedicine"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01902","article-title":"Epstein-Barr virus and hemophagocytic lymphohistiocytosis","volume":"8","author":"Marsh RA","year":"2017","unstructured":"Marsh RA. Epstein-Barr virus and hemophagocytic lymphohistiocytosis. Front Immunol. 2017, 8:10.3389\/fimmu.2017.01902","journal-title":"Front Immunol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2018.198655","article-title":"Treatment outcomes and prognostic factors in adult patients with secondary hemophagocytic lymphohistiocytosis not associated with malignancy","volume":"104","author":"Yoon JH","year":"2019","unstructured":"Yoon JH, Park SS, Jeon YW, et al.. Treatment outcomes and prognostic factors in adult patients with secondary hemophagocytic lymphohistiocytosis not associated with malignancy. Haematologica. 2019, 104:269-76. 10.3324\/haematol.2018.198655","journal-title":"Haematologica"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.22541\/au.175466539.96762146\/v1","article-title":"A rare potentially fatal complication of a common virus: Epstein-Barr virus-induced hemophagocytic lymphohistiocytosis in adolescence [PREPRINT]","author":"Alhayek B","year":"2025","unstructured":"Alhayek B, Malone X, Mislay JA, Sentmanat MK, Cardew RT, Ramsakal A. A rare potentially fatal complication of a common virus: Epstein-Barr virus-induced hemophagocytic lymphohistiocytosis in adolescence [PREPRINT]. Authorea. 2025, 10.22541\/au.175466539.96762146\/v1","journal-title":"Authorea"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1080\/15384047.2021.1996139","article-title":"Requirement for containing etoposide in the initial treatment of lymphoma associated hemophagocytic lymphohistiocytosis","volume":"22","author":"Song Y","year":"2021","unstructured":"Song Y, Wang J, Wang Y, Wu L, Wang Z. Requirement for containing etoposide in the initial treatment of lymphoma associated hemophagocytic lymphohistiocytosis. Cancer Biol Ther. 2021, 22:598-606. 10.1080\/15384047.2021.1996139","journal-title":"Cancer Biol Ther"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2024-202645","article-title":"Secondary hemophagocytic lymphohistiocytosis (HLH): a systematic review of incidence and prognostic outcomes","volume":"144","author":"Hameed M","year":"2024","unstructured":"Hameed M, Garcia G, Zhen KC, Hartenstein B, Herrera LDJ, Hamad K, Wiese-Rometsch W. Secondary hemophagocytic lymphohistiocytosis (HLH): a systematic review of incidence and prognostic outcomes. Blood. 2024, 144:5374. 10.1182\/blood-2024-202645","journal-title":"Blood"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-024-01621-x","article-title":"Hemophagocytic lymphohistiocytosis: current treatment advances, emerging targeted therapy and underlying mechanisms","volume":"17","author":"Wu Y","year":"2024","unstructured":"Wu Y, Sun X, Kang K, Yang Y, Li H, Zhao A, Niu T. Hemophagocytic lymphohistiocytosis: current treatment advances, emerging targeted therapy and underlying mechanisms. J Hematol Oncol. 2024, 17:106. 10.1186\/s13045-024-01621-x","journal-title":"J Hematol Oncol"},{"key":"ref13","article-title":"Epstein-Barr virus-induced hemophagocytic lymphohistiocytosis","volume":"7","author":"Goudarzipour K","year":"2013","unstructured":"Goudarzipour K, Kajiyazdi M, Mahdaviyani A. Epstein-Barr virus-induced hemophagocytic lymphohistiocytosis. Int J Hematol Oncol Stem Cell Res. 2013, 7:42-5.","journal-title":"Int J Hematol Oncol Stem Cell Res"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmii.2011.01.027","article-title":"Causes, clinical symptoms, and outcomes of infectious diseases associated with hemophagocytic lymphohistiocytosis in Taiwanese adults","volume":"44","author":"Tseng YT","year":"2011","unstructured":"Tseng YT, Sheng WH, Lin BH, Lin CW, Wang JT, Chen YC, Chang SC. Causes, clinical symptoms, and outcomes of infectious diseases associated with hemophagocytic lymphohistiocytosis in Taiwanese adults. J Microbiol Immunol Infect. 2011, 44:191-7. 10.1016\/j.jmii.2011.01.027","journal-title":"J Microbiol Immunol Infect"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-03-278127","article-title":"How I treat hemophagocytic lymphohistiocytosis","volume":"118","author":"Jordan MB","year":"2011","unstructured":"Jordan MB, Allen CE, Weitzman S, Filipovich AH, McClain KL. How I treat hemophagocytic lymphohistiocytosis. Blood. 2011, 118:4041-52. 10.1182\/blood-2011-03-278127","journal-title":"Blood"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2018894618","article-title":"Recommendations for the management of hemophagocytic lymphohistiocytosis in adults","volume":"133","author":"La Ros\u00e9e P","year":"2019","unstructured":"La Ros\u00e9e P, Horne A, Hines M, et al.. Recommendations for the management of hemophagocytic lymphohistiocytosis in adults. Blood. 2019, 133:2465-77. 10.1182\/blood.2018894618","journal-title":"Blood"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12386","article-title":"Treatment of Epstein Barr virus-induced haemophagocytic lymphohistiocytosis with rituximab-containing chemo-immunotherapeutic regimens","volume":"162","author":"Chellapandian D","year":"2013","unstructured":"Chellapandian D, Das R, Zelley K, Wiener SJ, Zhao H, Teachey DT, Nichols KE. Treatment of Epstein Barr virus-induced haemophagocytic lymphohistiocytosis with rituximab-containing chemo-immunotherapeutic regimens. Br J Haematol. 2013, 162:376-82. 10.1111\/bjh.12386","journal-title":"Br J Haematol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms11071694","article-title":"Management of complex infections in hemophagocytic lymphohistiocytosis in adults","volume":"11","author":"Zhang Y","year":"2023","unstructured":"Zhang Y, Cheng Z, Hu Y, Tang LV. Management of complex infections in hemophagocytic lymphohistiocytosis in adults. Microorganisms. 2023, 11:10.3390\/microorganisms11071694","journal-title":"Microorganisms"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2023.03.006","article-title":"Immune effector cell-associated hemophagocytic lymphohistiocytosis-like syndrome","volume":"29","author":"Hines MR","year":"2023","unstructured":"Hines MR, Knight TE, McNerney KO, et al.. Immune effector cell-associated hemophagocytic lymphohistiocytosis-like syndrome. Transplant Cell Ther. 2023, 29:438. 10.1016\/j.jtct.2023.03.006","journal-title":"Transplant Cell Ther"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/406974-a-rare-potentially-fatal-complication-of-a-common-virus-epstein-barr-virus-induced-hemophagocytic-lymphohistiocytosis-in-adolescence","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T14:43:28Z","timestamp":1760885008000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/406974-a-rare-potentially-fatal-complication-of-a-common-virus-epstein-barr-virus-induced-hemophagocytic-lymphohistiocytosis-in-adolescence"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,19]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.94918","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10,19]]}}}